Selected research
Industry Research
Peanut Allergy Vaccine Industry Research Report 2026
Market perspective
The global Peanut Allergy Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Peanut Allergy Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Peanut Allergy Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Peanut Allergy Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Peanut Allergy Vaccine include Astellas, Immunomic Therapeutic, Aravax, Allergy Therapeutics and Aimmune, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Peanut Allergy Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Peanut Allergy Vaccine Market by Company
Astellas
Immunomic Therapeutic
Aravax
Allergy Therapeutics
Aimmune
Peanut Allergy Vaccine Segment by Type
ASP0892
AR101
Others
Peanut Allergy Vaccine Segment by Application
Government Agencies
Hospitals
Personal Clinics
Others
Peanut Allergy Vaccine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peanut Allergy Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peanut Allergy Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peanut Allergy Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Peanut Allergy Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Peanut Allergy Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Peanut Allergy Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- ASP0892
- AR101
- Others
Applications
- Government Agencies
- Hospitals
- Personal Clinics
- Others
Companies covered
- Astellas
- Immunomic Therapeutic
- Aravax
- Allergy Therapeutics
- Aimmune
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Peanut Allergy Vaccine Market Size (2021-2032)
- 2.2.2 Global Peanut Allergy Vaccine Sales (2021-2032)
- 2.2.3 Global Peanut Allergy Vaccine Market Average Price (2021-2032)
- 2.3 Peanut Allergy Vaccine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 ASP0892
- 2.3.3 AR101
- 2.3.4 Others
- 2.4 Peanut Allergy Vaccine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Government Agencies
- 2.4.3 Hospitals
- 2.4.4 Personal Clinics
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Peanut Allergy Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Peanut Allergy Vaccine Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Peanut Allergy Vaccine Revenue of Manufacturers (2021-2026)
- 3.4 Global Peanut Allergy Vaccine Average Price by Manufacturers (2021-2026)
- 3.5 Global Peanut Allergy Vaccine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Peanut Allergy Vaccine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Peanut Allergy Vaccine, Product Type & Application
- 3.8 Global Manufacturers of Peanut Allergy Vaccine, Established Date
- 3.9 Global Peanut Allergy Vaccine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Astellas
- 4.1.1 Astellas Company Information
- 4.1.2 Astellas Business Overview
- 4.1.3 Astellas Peanut Allergy Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Astellas Peanut Allergy Vaccine Product Portfolio
- 4.1.5 Astellas Recent Developments
- 4.2 Immunomic Therapeutic
- 4.2.1 Immunomic Therapeutic Company Information
- 4.2.2 Immunomic Therapeutic Business Overview
- 4.2.3 Immunomic Therapeutic Peanut Allergy Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Immunomic Therapeutic Peanut Allergy Vaccine Product Portfolio
- 4.2.5 Immunomic Therapeutic Recent Developments
- 4.3 Aravax
- 4.3.1 Aravax Company Information
- 4.3.2 Aravax Business Overview
- 4.3.3 Aravax Peanut Allergy Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Aravax Peanut Allergy Vaccine Product Portfolio
- 4.3.5 Aravax Recent Developments
- 4.4 Allergy Therapeutics
- 4.4.1 Allergy Therapeutics Company Information
- 4.4.2 Allergy Therapeutics Business Overview
- 4.4.3 Allergy Therapeutics Peanut Allergy Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Allergy Therapeutics Peanut Allergy Vaccine Product Portfolio
- 4.4.5 Allergy Therapeutics Recent Developments
- 4.5 Aimmune
- 4.5.1 Aimmune Company Information
- 4.5.2 Aimmune Business Overview
- 4.5.3 Aimmune Peanut Allergy Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Aimmune Peanut Allergy Vaccine Product Portfolio
- 4.5.5 Aimmune Recent Developments
5 Global Peanut Allergy Vaccine Market Scenario by Region
- 5.1 Global Peanut Allergy Vaccine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Peanut Allergy Vaccine Sales by Region: 2021-2032
- 5.2.1 Global Peanut Allergy Vaccine Sales by Region: 2021-2026
- 5.2.2 Global Peanut Allergy Vaccine Sales by Region: 2027-2032
- 5.3 Global Peanut Allergy Vaccine Revenue by Region: 2021-2032
- 5.3.1 Global Peanut Allergy Vaccine Revenue by Region: 2021-2026
- 5.3.2 Global Peanut Allergy Vaccine Revenue by Region: 2027-2032
- 5.4 North America Peanut Allergy Vaccine Market Facts & Figures by Country
- 5.4.1 North America Peanut Allergy Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Peanut Allergy Vaccine Sales by Country (2021-2032)
- 5.4.3 North America Peanut Allergy Vaccine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Peanut Allergy Vaccine Market Facts & Figures by Country
- 5.5.1 Europe Peanut Allergy Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Peanut Allergy Vaccine Sales by Country (2021-2032)
- 5.5.3 Europe Peanut Allergy Vaccine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Peanut Allergy Vaccine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Peanut Allergy Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Peanut Allergy Vaccine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Peanut Allergy Vaccine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Peanut Allergy Vaccine Market Facts & Figures by Country
- 5.7.1 South America Peanut Allergy Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Peanut Allergy Vaccine Sales by Country (2021-2032)
- 5.7.3 South America Peanut Allergy Vaccine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Peanut Allergy Vaccine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Peanut Allergy Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Peanut Allergy Vaccine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Peanut Allergy Vaccine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Peanut Allergy Vaccine Sales by Type (2021-2032)
- 6.1.1 Global Peanut Allergy Vaccine Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Peanut Allergy Vaccine Sales Market Share by Type (2021-2032)
- 6.2 Global Peanut Allergy Vaccine Revenue by Type (2021-2032)
- 6.2.1 Global Peanut Allergy Vaccine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Peanut Allergy Vaccine Revenue Market Share by Type (2021-2032)
- 6.3 Global Peanut Allergy Vaccine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Peanut Allergy Vaccine Sales by Application (2021-2032)
- 7.1.1 Global Peanut Allergy Vaccine Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Peanut Allergy Vaccine Sales Market Share by Application (2021-2032)
- 7.2 Global Peanut Allergy Vaccine Revenue by Application (2021-2032)
- 7.2.1 Global Peanut Allergy Vaccine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Peanut Allergy Vaccine Revenue Market Share by Application (2021-2032)
- 7.3 Global Peanut Allergy Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Peanut Allergy Vaccine Value Chain Analysis
- 8.1.1 Peanut Allergy Vaccine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Peanut Allergy Vaccine Production Mode & Process
- 8.2 Peanut Allergy Vaccine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Peanut Allergy Vaccine Distributors
- 8.2.3 Peanut Allergy Vaccine Customers
9 Global Peanut Allergy Vaccine Analyzing Market Dynamics
- 9.1 Peanut Allergy Vaccine Industry Trends
- 9.2 Peanut Allergy Vaccine Industry Drivers
- 9.3 Peanut Allergy Vaccine Industry Opportunities and Challenges
- 9.4 Peanut Allergy Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst